AlphaNooner by AdvisorShares

What leads someone to consider psychedelic medicine, and what changes their mind about it?

Navy veteran Graham Ginn joins AlphaNooner to share how childhood trauma, a mental health crisis, and a later cancer diagnosis shaped his journey from skepticism to psychedelic advocacy.

Ahead of Veterans Day, the conversation explores how veterans are helping change public perceptions of psychedelics, while highlighting the many reasons people seek help across military and civilian life.

In this episode:

• Graham's story: Confronting childhood trauma and patterns of self-sabotage that followed him into adulthood. • A change in perspective: How he describes the impact of psychedelic experiences on his relationships, sense of purpose, and fear of death. • Preparation and integration: Why the work surrounding a psychedelic experience matters. • Challenging stigma: How veterans' experiences are opening conversations about mental health and treatment options. • Expanding access: Graham's views on research, advocacy, and the proposed Freedom to Heal Act.

This conversation reflects personal experiences and opinions. It is for educational purposes and is not medical advice.

AlphaNooner by AdvisorShares brings you timely conversations with investors, market strategists, portfolio managers and industry experts on markets, investment themes and the stories shaping what comes next.

Watch the full video on YouTube: https://www.youtube.com/watch?v=2fSI2WvJ_HQ

Follow AdvisorShares (@advisorshares) on YouTube, X, LinkedIn, Instagram and Facebook.

What is AlphaNooner by AdvisorShares?

ALPHANOONER
Markets. Themes. The people investing in what comes next.